On the Origins of Hepatitis C Virus NS5B Polymerase Inhibitory Activity Using Machine Learning Approaches

2015 ◽  
Vol 15 (18) ◽  
pp. 1814-1826 ◽  
Author(s):  
Apilak Worachartcheewan ◽  
Veda Prachayasittikul ◽  
Nuttapat Anuwongcharoen ◽  
Watshara Shoombuatong ◽  
Virapong Prachayasittikul ◽  
...  
2016 ◽  
Vol 17 (13) ◽  
pp. 1560-1576 ◽  
Author(s):  
Yuanchao Xie ◽  
Comfort Alicha Ogah ◽  
Xiangrui Jiang ◽  
Jianfeng Li ◽  
Jingshan Shen

2010 ◽  
Vol 20 (9) ◽  
pp. 2968-2973 ◽  
Author(s):  
Matthew G. LaPorte ◽  
Tandy L. Draper ◽  
Lori E. Miller ◽  
Charles W. Blackledge ◽  
Lara K. Leister ◽  
...  

2005 ◽  
Vol 48 (14) ◽  
pp. 4547-4557 ◽  
Author(s):  
Steven Harper ◽  
Salvatore Avolio ◽  
Barbara Pacini ◽  
Marcello Di Filippo ◽  
Sergio Altamura ◽  
...  

2011 ◽  
Vol 90 (2) ◽  
pp. A75
Author(s):  
S. Priet ◽  
I. Zlatev ◽  
I. Barvik ◽  
J. Neyts ◽  
H. Dutartre ◽  
...  

2013 ◽  
Vol 91 (1) ◽  
pp. 66-81 ◽  
Author(s):  
Pierre L. Beaulieu ◽  
René Coulombe ◽  
James Gillard ◽  
Christian Brochu ◽  
Jianmin Duan ◽  
...  

Acylsulfonamide and acylsulfamide as surrogates for the carboxylic acid function of N-acetamide-indole-6-carboxylic acids were evaluated as allosteric inhibitors of hepatitis C virus (HCV) NS5B polymerase. Several analogs displayed excellent antiviral potency against both 1a and 1b HCV genotypes in cell-based subgenomic replicon assays. Structure–activity relationships (SAR) are discussed in the context of the crystal structure of an inhibitor − NS5B polymerase complex. Absorption, distribution, metabolism, and excretion pharmacokinetic (ADME-PK) properties of this class of inhibitors are also described.


2014 ◽  
Vol 55 (28) ◽  
pp. 3813-3816 ◽  
Author(s):  
Qun Dang ◽  
Zhibo Zhang ◽  
Bingyu Tang ◽  
Yang Song ◽  
Ling Wu ◽  
...  

2016 ◽  
Vol 1117 ◽  
pp. 227-239 ◽  
Author(s):  
Wenlian Li ◽  
Hongzong Si ◽  
Yang Li ◽  
Cuizhu Ge ◽  
Fucheng Song ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document